These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 37418288)
1. Biodistribution and Internal Dosimetry of 68 Ga-DOTA-IBA PET Imaging for Patients With Bone Metastases. Yang J; Deng J; Fan D; Chen G; Lu Z; Liu H; Mok GSP; Chen Y Clin Nucl Med; 2023 Oct; 48(10):847-852. PubMed ID: 37418288 [TBL] [Abstract][Full Text] [Related]
2. Preliminary results of biodistribution and dosimetric analysis of [ Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA Ann Nucl Med; 2019 Jun; 33(6):404-413. PubMed ID: 30877560 [TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of 68 Ga- or 177 Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases : A Phase 0/I Study. Qiu L; Wang Y; Liu H; Wang Q; Chen L; Liu L; Wang L; Feng Y; Chen Y Clin Nucl Med; 2023 Jun; 48(6):489-496. PubMed ID: 36976706 [TBL] [Abstract][Full Text] [Related]
4. Biodistribution and dosimetry of Li H; Pei W; Yang X; Qu G; Hua Q; Liu L; Wang Y; Xu T; Chen Y EJNMMI Res; 2024 Mar; 14(1):30. PubMed ID: 38517637 [TBL] [Abstract][Full Text] [Related]
5. Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [ Doot RK; Young AJ; Daube-Witherspoon ME; Alexoff D; Labban KJ; Lee H; Wu Z; Zha Z; Choi SR; Ploessl KH; Schubert EK; Lee H; Zhu L; Reddin JS; Karp JS; Kung H; Pryma DA Nucl Med Biol; 2020; 86-87():1-8. PubMed ID: 32361089 [TBL] [Abstract][Full Text] [Related]
6. Biodistribution and post-therapy dosimetric analysis of [ Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA EJNMMI Res; 2019 Nov; 9(1):102. PubMed ID: 31781962 [TBL] [Abstract][Full Text] [Related]
7. Zhang J; Lin Z; Zhang X; Lin R; Cui M; Miao W; Yao S Front Bioeng Biotechnol; 2021; 9():811972. PubMed ID: 35155411 [No Abstract] [Full Text] [Related]
8. Radiation Dosimetry and Biodistribution of Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685 [TBL] [Abstract][Full Text] [Related]
9. Biodistribution, pharmacokinetics, dosimetry of [ Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617 [TBL] [Abstract][Full Text] [Related]
10. [44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma. Khawar A; Eppard E; Sinnes JP; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA Clin Nucl Med; 2018 May; 43(5):323-330. PubMed ID: 29485430 [TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
12. Clinical Internal Dosimetry and Biodistribution of 177 Lu-DOTA-Trastuzumab in HER2-Positive Metastatic and Locally Advanced Breast Carcinoma. Narwadkar YS; Parghane RV; Sahu S; Lad S; Deep K; Wanage G; Suralkar T; Banerjee S; Gupta S; Basu S; Badwe RA Clin Nucl Med; 2024 Apr; 49(4):e149-e155. PubMed ID: 38350067 [TBL] [Abstract][Full Text] [Related]
13. Clinical Translation and First In-Human Use of [ Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832 [TBL] [Abstract][Full Text] [Related]
14. First-in-Humans Study of Viitanen R; Moisio O; Lankinen P; Li XG; Koivumäki M; Suilamo S; Tolvanen T; Taimen K; Mali M; Kohonen I; Koskivirta I; Oikonen V; Virtanen H; Santalahti K; Autio A; Saraste A; Pirilä L; Nuutila P; Knuuti J; Jalkanen S; Roivainen A J Nucl Med; 2021 Apr; 62(4):577-583. PubMed ID: 32817143 [TBL] [Abstract][Full Text] [Related]
15. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans. Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613 [TBL] [Abstract][Full Text] [Related]
16. Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer. Pfob CH; Ziegler S; Graner FP; Köhner M; Schachoff S; Blechert B; Wester HJ; Scheidhauer K; Schwaiger M; Maurer T; Eiber M Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1962-70. PubMed ID: 27207281 [TBL] [Abstract][Full Text] [Related]
17. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers. Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934 [TBL] [Abstract][Full Text] [Related]
18. First Evaluation of PET-Based Human Biodistribution and Dosimetry of Savi A; Incerti E; Fallanca F; Bettinardi V; Rossetti F; Monterisi C; Compierchio A; Negri G; Zannini P; Gianolli L; Picchio M J Nucl Med; 2017 Aug; 58(8):1224-1229. PubMed ID: 28209906 [No Abstract] [Full Text] [Related]
19. Biodistribution and radiation dose estimates for Krebs S; Pandit-Taskar N; Reidy D; Beattie BJ; Lyashchenko SK; Lewis JS; Bodei L; Weber WA; O'Donoghue JA Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):677-685. PubMed ID: 30374529 [TBL] [Abstract][Full Text] [Related]
20. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging. Persson M; El Ali HH; Binderup T; Pfeifer A; Madsen J; Rasmussen P; Kjaer A Nucl Med Biol; 2014 Mar; 41(3):290-5. PubMed ID: 24533988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]